Stockreport

Gilead Collaborates With German Biotech Tubulis for Solid Tumor ADC [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF The collaboration is aimed at discovering and developing an antibody-drug conjugate (ADC) against a solid tumor target. Gilead's shares have risen 14.2% year to date [Read more]